Table 1.
Baseline demographic and health status characteristics of the patients for each enrolled family.
| Patient characteristics | Cystic fibrosis (n=51) | Inflammatory bowel disease (n=37) | Full sample (N=88) | ||||
| Patient age (years), mean (SD) | 10.55 (6.01) | 15.70 (4.02) | 12.72 (5.82) | ||||
|
|
0-2, n (%) | 7 (14) | 1 (3) | 8 (9) | |||
|
|
3-12, n (%) | 24 (47) | 9 (24) | 33 (38) | |||
|
|
12-21, n (%) | 20 (39) | 27 (73) | 47 (53) | |||
| Patient gender, n (%) | |||||||
|
|
Female | 24 (47) | 22 (60) | 46 (52) | |||
|
|
Male | 27 (53) | 15 (40) | 42 (48) | |||
| Patient race, n (%) | |||||||
|
|
White | 49 (96) | 35 (95) | 84 (96) | |||
|
|
Black or African American | 0 (0) | 2 (5) | 2 (2) | |||
|
|
Other | 2 (4) | 0 (0) | 2 (2) | |||
| Disease indicators, mean (SD) | |||||||
|
|
Mean forced expiratory volume in 1 second percent predicteda,b (cystic fibrosis only, n=38) | 96.89 (19.69) | —c | —c | |||
|
|
Disease type (inflammatory bowel disease only) | —d |
|
—d | |||
|
|
Physicians global assessment score (inflammatory bowel disease only) | —d |
|
—d | |||
| Family income (US $), n (%) | |||||||
|
|
<25,000 | 4 (8) | 3 (8) | 7 (8) | |||
|
|
25,000 to 49,999 | 12 (24) | 1 (2) | 13 (15) | |||
|
|
50,000 to 74,999 | 8 (15) | 5 (14) | 13 (15) | |||
|
|
75,000 to 99,999 | 9 (18) | 7 (19) | 16 (18) | |||
|
|
≥100,000 | 15 (29) | 14 (38) | 29 (33) | |||
|
|
Unknown | 3 (6) | 7 (19) | 10 (11) | |||
aScores ranged between 48 and 127.
bNot all participants were old enough to reliably complete pulmonary function testing.
cMeasure not applicable for patients with inflammatory bowel disease.
dMeasure not applicable for patients with cystic fibrosis.